Paralysis case and contact spread of recombinant vaccine-derived poliovirus, Spain

Emerging Infectious Diseases

Volumn 14, Issue 11, 2008, Pages 1807-1809

  Avellón, Ana ^a   Cabrerizo, Maria ^a   De Miguel, Teresa ^a   Pérez Breña, Pilar ^a   Tenorio, Antonio ^a   Pérez, Jose Luis ^c   Martínez De Aragón, Maria Victoria ^b   Trallero, Gloria ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b CARLOS III INSTITUTE OF HEALTH   (Spain)

^c HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

POLIOMYELITIS VACCINE; RECOMBINANT VACCINE;

HUMAN; IMMUNOTHERAPY; LETTER; NONHUMAN; PARALYSIS; POLIOMYELITIS; POLIOMYELITIS VIRUS; SPAIN; VACCINATION; VIRUS DETECTION; VIRUS REPLICATION;

ADOLESCENT; ADULT; CAPSID PROTEINS; CHILD; DISEASE OUTBREAKS; FATAL OUTCOME; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; MALE; PARALYSIS; POLIOMYELITIS; POLIOVIRUS VACCINE, ORAL; SEQUENCE HOMOLOGY, AMINO ACID; SPAIN; VACCINATION; VACCINES, SYNTHETIC;

EID: 55549093120     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1411.080517     Document Type: Letter

References (10)

1. Dowdle W, Kew O. Vaccine-derived polioviruses: is it time to stop using the word "rare"? J Infect Dis. 2006;194:539-41. DOI: 10.1086/506368
2. Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol. 2005;59:587-635. DOI: 10.1146/annurev.micro.58. 030603.123625
3. Trallero G, Avellon A, Otero A, de Miguel T, Alonso M, Perez-Brena P. Laboratory Network within the Polio Eradication Initiative (1998-2003): six years of surveillance for acute flaccid paralysis in Spain [in Spanish]. Enferm Infecc Microbiol Clin. 2006;24:167-72. DOI: 10.1157/13086549
4. Casas I, Palacios GF, Trallero G, Cisterna D, Freire MC, Tenorio A. Molecular characterization of human enteroviruses in clinical samples: comparison between VP2, VP1, and RNA polymerase regions using RT nested PCR assays and direct sequencing of products. J Med Virol. 2001;65:138-48. DOI: 10.1002/jmv.2013
5. Casas I, Tenorio A, Echevarria JM, Klapper PE, Cleator GM. Detection of enteroviral RNA and specific DNA of herpesviruses by multiplex genome amplification. J Virol Methods. 1997;66:39-50. DOI: 10.1016/S0166-0934(97)00035- 9
6. Yang CF, De L, Holloway BP, Pallansch MA, Kew OM. Detection and identification of vaccine-related polioviruses by the polymerase chain reaction. Virus Res. 1991;20:159-79. DOI: 10.1016/0168-1702(91)90107-7
7. Cherkasova EA, Yakovenko ML, Rezapkin GV, Korotkova EA, Ivanova OE, Eremeeva TP, et al. Spread of vaccine-derived poliovirus from a paralytic case in an immunodeficient child: an insight into the natural evolution of oral polio vaccine. J Virol. 2005;79:1062-70. DOI: 10.1128/JVI.79.2.1062-1070.2005
8. Karakasiliotis I, Paximadi E, Markoulatos P. Evolution of a rare vaccine-derived multirecombinant poliovirus. J Gen Virol. 2005;86:3137-42. DOI: 10.1099/vir.0.80823-0
9. Korotkova EA, Park R, Cherkasova EA, Lipskaya GY, Chumakov KM, Feldman EV, et al. Retrospective analysis of a local cessation of vaccination against poliomyelitis: a possible scenario for the future. J Virol. 2003;77:12460-5. DOI: 10.1128/JVI.77.23.12460-12465.2003
10. Parvaneh N, Shahmahmoudi S, Tabatabai H, Zahraei M, Mousavi T, Esteghamati AR, et al. Vaccine-associated paralytic poliomyelitis in a patient with MHC class II deficiency. J Clin Virol. 2007;39:145-8. DOI: 10.1016/j.jcv.2007.04.002